Killing activity of rifampin with piperacillin therapy against adherent cells of Pseudomonas aeruginosa

Journal of Chemotherapy

Volumn 20, Issue 5, 2008, Pages 652-654

  Garey, Kevin W ^a   Martorell, M V ^a   Vo, Q P ^a   Tam, V H ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIPERACILLIN; RIFAMPICIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BACTERIUM ISOLATE; CATHETER INFECTION; CELL ADHESION; CELL DEATH; COLONY FORMING UNIT; CONTROLLED STUDY; DILUTION; DRUG EFFICACY; GRAM NEGATIVE INFECTION; INCUBATION TEMPERATURE; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 57049085886     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.5.652     Document Type: Article

References (17)

1. Hanna H, Afif C, Alakech B, et al. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 2004;25(8):646-9.
2. Tanriover B, Carlton D, Saddekni S, et al. Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies. Kidney Int 2000;57(5):2151-5.
3. Passerini L, Lam K, Costerton JW, King EG. Biofilms on indwelling vascular catheters. Crit Care Med 1992;20(5):665-73.
4. Donlan RM. Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 2001;33(8):1387-92.
5. Drenkard E. Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 2003;5(13):1213-9.
6. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother 2000;44(7):1818-24.
7. Chang FY. Staphylococcus aureus bacteremia and endocarditis. J Microbiol Immunol Infect 2000;33(2):63-8.
8. Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum sensing in Staphylococcus aureus biofilms. J Bacteriol 2004;186(6):1838-50.
9. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M7-A5. National Committee for Clinical Laboratory Standards W, Pa.
10. O'Toole GA, Pratt LA, Watnick PI, Newman DK, Weaver VB, Kolter R. Genetic approaches to study of biofilms. Methods Enzymol 1999;310:91-109.
11. Kim MK, Xuan D, Quintiliani R, Nightingale CH, Nicolau DP. Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam. J Antimicrob Chemother 2001;48(2):259-67.
12. Droste JA, Verweij-van Wissen CP, Kearney BP, et al. Pharmacokinetic study of tenofovir disoproxil furnarate combined with rifampin in healthy volunteers. Antimicrob Agents Chemother 2005;49(2):680-4.
13. Herigstad B, Hamilton M, Heersink J. How to optimize the drop plate method for enumerating bacteria. J Microbiol Methods 2001;44(2):121-9.
14. Ch 22. Two-factor studies- Unequal sample sizes and unequal treatment importance. In: Neter J, Kutner MH, Nachtsheim CJ, Wasserman W, eds. Applied Linear Statistical Models. 4th ed. Boston: WCB/ McGraw-Hill:889-923.
15. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997;127(4):275-80.
16. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol 2005;13(1):34-40.
17. Zimmerli W, Frei R, Widmer AF, Rajacic Z. Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother 1994; 33(5):959-67.